Sub-regional analysis of the parotid glands: model development for predicting late xerostomia with radiomics features in head and neck cancer patients

References

• Berger T, Noble DJ, Shelley LEA, et al. 50 Years of radiotherapy research: evolution, trends and lessons for the future. Radiother Oncol. 2021;165:75–86.
   PubMed Web of Science ®Google Scholar
• Wijers OB, Levendag PC, Braaksma MMJ, et al. Patients with head and neck cancer cured by radiation therapy: a survey of the dry mouth syndrome in long-term survivors. Head Neck. 2002;24(8):737–747.
   PubMed Web of Science ®Google Scholar
• Sim CPC, Soong YL, Pang EPP, et al. Xerostomia, salivary characteristics and gland volumes following intensity-modulated radiotherapy for nasopharyngeal carcinoma: a two-year follow up. Aust Dent J. 2018;63(2):217–223.
   PubMed Web of Science ®Google Scholar
• Owosho AA, Thor M, Oh JH, et al. The role of parotid gland irradiation in the development of severe hyposalivation (xerostomia) after intensity-modulated radiation therapy for head and neck cancer: temporal patterns, risk factors, and testing the QUANTEC guidelines. J Craniomaxillofac Surg. 2017;45(4):595–600.
   PubMed Web of Science ®Google Scholar
• Gabryś HS, Buettner F, Sterzing F, et al. Parotid gland mean dose as a xerostomia predictor in low-dose domains. Acta Oncol. 2017;56(9):1197–1203.
   PubMed Web of Science ®Google Scholar
• Konings AWT, Cotteleer F, Faber H, et al. Volume effects and region-dependent radiosensitivity of the parotid gland. Int J Radiat Oncol Biol Phys. 2005;62(4):1090–1095.
   PubMed Web of Science ®Google Scholar
• Van Luijk P, Pringle S, Deasy JO, et al. Sparing the region of the salivary gland containing stem cells preserves saliva production after radiotherapy for head and neck cancer. Sci Transl Med. 2015;7(305):305ra147.
   PubMed Web of Science ®Google Scholar
• Fried D V, Zhu T, Das SK, et al. Prospective assessment of sparing the parotid ducts via MRI sialography for reducing patient reported xerostomia. Radiother Oncol. 2022;172:42–49.
   PubMed Web of Science ®Google Scholar
• Miah AB, Gulliford SL, Morden J, et al. Recovery of salivary function: contralateral parotid-sparing intensity-modulated radiotherapy versus bilateral superficial lobe parotid-sparing intensity-modulated radiotherapy. Clin Oncol. 2016;28(9):e69–76–e76.
   Web of Science ®Google Scholar
• van Dijk LV, Brouwer CL, van der Schaaf A, et al. CT image biomarkers to improve patient-specific prediction of radiation-induced xerostomia and sticky saliva. Radiother Oncol. 2017;122(2):185–191.
   PubMed Web of Science ®Google Scholar
• van Dijk LV, Thor M, Steenbakkers RJHM, et al. Parotid gland fat related magnetic resonance image biomarkers improve prediction of late radiation-induced xerostomia. Radiother Oncol. 2018;128(3):459–466.
   PubMed Web of Science ®Google Scholar
• van Dijk LV, Noordzij W, Brouwer CL, et al. 18 F-FDG PET image biomarkers improve prediction of late radiation-induced xerostomia. Radiother Oncol. 2018;126(1):89–95.
   PubMed Web of Science ®Google Scholar
• Wilkie JR, Mierzwa ML, Casper KA, et al. Predicting late radiation-induced xerostomia with parotid gland PET biomarkers and dose metrics. Radiother Oncol. 2020;148:30–37.
   PubMed Web of Science ®Google Scholar
• Yip SSF, Aerts HJWL. Applications and limitations of radiomics. Phys Med Biol. 2016;61(13):R150–166.
   PubMed Web of Science ®Google Scholar
• Mayerhoefer ME, Materka A, Langs G, et al. Introduction to radiomics. J Nucl Med. 2020;61(4):488–495.
   PubMed Web of Science ®Google Scholar
• Piotrowski T, Gintowt K, Jodda A, et al. Impact of the intra- and inter-observer variability in the delineation of parotid glands on the dose calculation during head and neck helical tomotherapy. Technol Cancer Res Treat. 2015;14(4):467–474.
   PubMed Web of Science ®Google Scholar
• Berger T, Noble DJ, Yang Z, et al. Assessing the generalisability of radiomics features previously identified as predictive of radiation-induced sticky saliva and xerostomia. Phys Imaging Radiat Oncol. 2022;25:100404.
   PubMedGoogle Scholar
• Ghadjar P, Fiorino C, Munck af Rosenschöld P, et al. ESTRO ACROP consensus guideline on the use of image guided radiation therapy for localized prostate cancer. Radiother Oncol. 2019;141:5–13.
   PubMed Web of Science ®Google Scholar
• Bell K, Licht N, Rübe C, et al. Image guidance and positioning accuracy in clinical practice: influence of positioning errors and imaging dose on the real dose distribution for head and neck cancer treatment. Radiat Oncol. 2018;13(1):190.
   Web of Science ®Google Scholar
• Berger T, Fokdal LU, Assenholt MS, et al. Robustness of elective lymph node target coverage with shrinking planning target volume margins in external beam radiotherapy of locally advanced cervical cancer. Phys Imaging Radiat Oncol. 2019;11:9–15.
   PubMedGoogle Scholar
• Rosen BS, Hawkins PG, Polan DF, et al. Early changes in serial CBCT-measured parotid gland biomarkers predict chronic xerostomia after head and neck radiation therapy. Int J Radiat Oncol Biol Phys. 2018;102(4):1319–1329.
   PubMed Web of Science ®Google Scholar
• van Timmeren JE, Leijenaar RTH, van Elmpt W, et al. Survival prediction of non-small cell lung cancer patients using radiomics analyses of cone-beam CT images. Radiother Oncol. 2017;123(3):363–369.
   PubMed Web of Science ®Google Scholar
• Berger T, Noble DJ, Shelley LEA, et al. Predicting radiotherapy-induced xerostomia in head and neck cancer patients using day-to-day kinetics of radiomics features. Phys Imaging Radiat Oncol. 2022;24:95–101.
   PubMedGoogle Scholar
• Sellami S, Bourbonne V, Hatt M, et al. Predicting response to radiotherapy of head and neck squamous cell carcinoma using radiomics from cone-beam CT images. Acta Oncol. 2022;61(1):73–80.
   PubMed Web of Science ®Google Scholar
• van Dijk LV, Langendijk JA, Zhai TT, et al. Delta-radiomics features during radiotherapy improve the prediction of late xerostomia. Sci Rep. 2019;9(1):1–8.
   PubMed Web of Science ®Google Scholar
• Burnet NG, Adams EJ, Fairfoul J, et al. Practical aspects of implementation of helical tomotherapy for intensity-modulated and image-guided radiotherapy. Clin Oncol (R Coll Radiol). 2010;22(4):294–312.
   PubMed Web of Science ®Google Scholar
• Burnet NG, Scaife JE, Romanchikova M, et al. Applying physical science techniques and CERN technology to an unsolved problem in radiation treatment for cancer: the multidisciplinary “VoxTox” research programme. CERN Ideasq J Exp Innov. 2017;1(1):3–12.
   PubMedGoogle Scholar
• Thomas SJ, Romanchikova M, Harrison K, et al. Recalculation of dose for each fraction of treatment on TomoTherapy. Br J Radiol. 2016;89(1059):20150770.
   Web of Science ®Google Scholar
• Zhang HB, Lu X, Huang SM, et al. Superficial parotid lobe–sparing delineation approach: a better method of dose optimization to protect the parotid gland in intensity-modulated radiotherapy for nasopharyngeal carcinoma. Current Oncology. 2013;20(6):e577–584.
   PubMed Web of Science ®Google Scholar
• Zwanenburg A, Vallières M, Abdalah MA, et al. The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping. Radiology. 2020;295(2):328–338.
   PubMed Web of Science ®Google Scholar
• The image biomarker standardisation initiative — IBSI 0.0.1dev documentation [Internet]. [cited 2021 Dec 23]. Available from: https://ibsi.readthedocs.io/en/latest/#%0Ahttps://ibsi.readthedocs.io/en/latest/.
   Google Scholar
• Moons KGM, Altman DG, Reitsma JB, et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med. 2015;162(1):W1–73.
   PubMed Web of Science ®Google Scholar
• Guo Y, Jiang W, Lakshminarayanan P, et al. Spatial radiation dose influence on xerostomia recovery and its comparison to acute incidence in patients with head and neck cancer. Adv Radiat Oncol. 2020;5(2):221–230.
   PubMedGoogle Scholar
• Han P, Lakshminarayanan P, Jiang W, et al. Dose/volume histogram patterns in salivary gland subvolumes influence xerostomia injury and recovery. Sci Rep. 2019;9(1):3616.
   Google Scholar
• Buettner F, Miah AB, Gulliford SL, et al. Novel approaches to improve the therapeutic index of head and neck radiotherapy: an analysis of data from the PARSPORT randomised phase III trial. Radiother Oncol. 2012;103(1):82–87.
   PubMed Web of Science ®Google Scholar
• Nevens D, Nuyts S. Can sparing of the superficial contralateral parotid lobe reduce xerostomia following radiotherapy for head and neck cancer? Br J Radiol. 2017;90(1080):20170596.
   PubMed Web of Science ®Google Scholar
• Kawamoto T, Nihei K, Nakajima Y, et al. Comparison of xerostomia incidence after three-dimensional conformal radiation therapy and contralateral superficial lobe parotid-sparing intensity-modulated radiotherapy for oropharyngeal and hypopharyngeal cancer. Auris Nasus Larynx. 2018;45(5):1073–1079.
   PubMed Web of Science ®Google Scholar
• Jeong J, Baek H, Kim YJ, et al. Human salivary gland stem cells ameliorate hyposalivation of radiation-damaged rat salivary glands. Exp Mol Med. 2013;45(11):e58–e58.
   PubMed Web of Science ®Google Scholar
• Ibrahim A, Primakov S, Beuque M, et al. Radiomics for precision medicine: current challenges, future prospects, and the proposal of a new framework. Methods. 2021;188:20–29.
   PubMed Web of Science ®Google Scholar
• Platform – E2-RADIatE [Internet]. [cited 2021 Dec 23]. Available from: https://project.eortc.org/e2-radiate/platform/.
   Google Scholar